Turkish Pharmaceutical Reimbursed Market Up 6% In 2013 With Alimentary, Metabolism Products Top Drivers
This article was originally published in PharmAsia News
Executive Summary
Turkey’s pharmaceutical market reached TL 15.3 billion ($6.92 billion) in 2013, gaining 6.4% to TL 13.7 billion ($6.19 billion) for reimbursed drugs, while non-reimbursed products gained 7% to TL 1.6 billion ($742.1 million).